ArticleLeukemia2026
Sequential treatment with ruxolitinib and imetelstat effectively depletes myelofibrosis hematopoietic stem and progenitor cells.
Xiaoli Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it